BDSI - BioDelivery Sciences International, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

BioDelivery Sciences International, Inc.

4131 ParkLake Avenue
Suite 225
Raleigh, NC 27612
United States
919-582-9050
http://www.bdsi.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees164

Key Executives

NameTitlePayExercisedYear Born
Mr. Herm CukierCEO & Director655.05kN/A1966
Mr. Scott M. PleshaPres & Chief Commercial Officer586.18kN/A1965
Mr. James Vollins J.D.Gen. Counsel, Chief Compliance Officer & Corp. Sec.77.08kN/A1969
Dr. Thomas B. Smith FAAFP, M.D.Chief Medical Officer217.86kN/A1961
Ms. Mary Theresa CoelhoCFO & TreasurerN/AN/A1962
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in opioid tolerant adult patients with cancer. The company also develops buprenorphine extended release injection, an injectable microparticle formulation of buprenorphine for the treatment of opioid dependence and chronic pain. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.

Corporate Governance

BioDelivery Sciences International, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 6. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 4; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.